(Updated - April 10, 2026 6:57 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Abbvie (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE